moxifloxacin has been researched along with uric acid in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (uric acid) | Trials (uric acid) | Recent Studies (post-2010) (uric acid) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 27,980 | 1,717 | 9,982 |
| Protein | Taxonomy | moxifloxacin (IC50) | uric acid (IC50) |
|---|---|---|---|
| Solute carrier family 2, facilitated glucose transporter member 9 | Homo sapiens (human) | 300 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bjursell, M; Dota, C; Gottfridsson, C; Johansson, S; Källgren, C; Kӧrnicke, T; Parkinson, J; Perl, S; Rekić, D | 1 |
1 trial(s) available for moxifloxacin and uric acid
| Article | Year |
|---|---|
Verinurad does not prolong QTc interval: a thorough QT study using concentration-QTc modelling.
Topics: Allopurinol; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Heart Rate; Humans; Long QT Syndrome; Moxifloxacin; Uric Acid | 2023 |